Effect of glycerol on local and systemic carcinogenicity of topically applied tobacco condensate. by Wilson, J. et al.
Br. J. Cancer (1978) 38, 250
EFFECT OF GLYCEROL ON LOCAL AND SYSTEMIC CARCINO-
GENICITY OF TOPICALLY APPLIED TOBACCO CONDENSATE
J. WILSON, M. J. L. CLAPP AND D. M. CONNINGt
From the Central Toxicology Laboratory, Inimperial Chemfical -Industries Ltd, Alderley 'ark, llacclesfield,
Cheshire SK1O 4TJ
Received ,3 Febiuary 1978 Accepted 8 May 1978
Summary.-When glycerol was added to tobacco smoke condensate in acetone sol-
vent, the topical carcinogenicity and the ability to produce epithelial hyperplasia in
mice was reduced. Two doses ofcondensate were applied, combined with2 concentra-
tions of added glycerol. Age-standardized results show that glycerol reduced the
incidence of tumours and malignant tumours and of hyperplasia in animals not
developing skin tumours. The relative incidences of malignant tumours, benign
tumours, hyperplasia and unaffected skin suggest that there is a sequential relation-
ship (i.e. normal skin to hyperplasia to benign neoplasia to malignant neoplasia)
which is impeded by glycerol. There was no systemic effect attributable to the
condensate.
IN STUDIES on the carcinogenicity of
smoke condensate of tobacco and NSM*
it was noted that NSM condensates showed
less than 250% of the tumour-producing
activity of tobacco (Clapp et al., 1977).
This was attributed to the general re-
duction of the particulate-phase activity
of NSM smoke, but comment was made
that the substantial carry-over into smoke
of the humectant used (glycerol) might
have been a factor ofsignificance. Glycerol
constitutes between 40%0 and 50°/ of the
particulate phase of NSM smoke and it
seemed possible that this amount might
influence the response of mouse skin to the
carcinogenic effect of smoke condensate,
quite apart from any effect of the dilution
of carcinogenic constituents. The experi-
ment described here was designed to
determine whether thepresenceofglycerol,
as a diluent of tobacco condensate, itself
influenced the carcinogenicity of the con-
densate irrespective of an effect on dosage.
MATERIALS AND METHODS
Cigarettes.-The cigarettes from which
condensate was prepared were 70 mm long
* Trade mark of New Smoking Materials Ltd.
tPresent ad(dress: B.I.B.R.A., Woodmansterne Roa
and 25-4 mm in circumference. They w%ere
made from a commercial blend of flue-cured
tobacco and contained no crushed stem. They
were supplied by Imperial Tobacco Limited,
Bristol.
Glycerol.-The glycerol was "Analar" re-
agent grade supplied by British Drug Houses
in a single bl)tch. It was stored at room
temperature.
Condensate preparation and application.-
The method was as previously reported (Clapp
et al., 1977), except that the acetone:water
solvent was used in the proportion of 80:20
v/v rather than the conventional 90:10 v/v in
order to minimize phase separation in those
condensate preparations which contained high
concentrations of glycerol.
Condensates were prepared at weekly
intervals, stored at room temperature and
applied to the animals with an ARH con-
tinuous pipetting unit (Arnold R. Horwell
Limited) through a stainless-steel cannula,
4 cm long and 2 mm diameter. The dose
applied was 0 3 ml per mouse, on 3 days each
week (Monday, Wednesday and Friday). All
condensates were shaken immediately before
painting each cageful of miice, and a fixed
volume was applied to each animal, differenit
doses being achieved by use of different con-
centrations. Undosed control animals were
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handled and shaved but not painted; solvent-
control animals were painted with equivalent
volumes of solvent or solvent/glycerol
mixtures.
Animals and treatment.-A total of 600
female specific-pathogen-free mice of an
Alderley Park albino strain, hysterectomy-
derived ofSwiss origin (ICI Limited, Pharma-
ceuticals Division, Alderley Park, Cheshire)
were used.
The mice were housed 10 per cage, fed
pasteurized cubed mouse diet (Oakes of
Congleton, Cheshire) and tap water ad
libitum. The cages measured 285x 280 x
10 cm, were made from 19-guage galvanized-
wire mesh and were suspended over collect-
ing trays lined with absorbent paper. The
animals were housed in one rack, and its
position within the animal room was changed
at intervals to avoid environmental effects of
ventilation, light or temperature fluctuations.
The animals were kept within a barriered-
maintained area throughout the experiment,
with the temperature maintained at about
22±17C and the relative humidity at about
55+10%.
After one week, mice were allocated to the
different groups on the basis of total body
weight per cage so as to give equal weight
distribution between the groups. Each was
clipped from the base of the tail to the nape
of the neck with an Oster A5 electric hair
clipper with a size-40 blade lubricated with
liquid paraffin. This was repeated weekly
throughout the study. Particular care was
taken to avoid lacerating the skin, especially
when tumours developed. A vacuum attach-
ment over the oscillating teeth reduced the
dispersion ofcontaminated hair into the room
atmosphere. Sometimes, in the early stages of
the experiment, the hair needed cleaning with
acetone to remove inspissated tar, before
clipping. Unpainted controlswereclippedonce
a week. Treatment after 2 weeks, when mice
were 6-7 weeks old and continued until
death, or until 108 weeks of treatment had
been completed.
All the experimental data were recorded on
cards (Copeland-Chattersen Company Ltd) so
that one card represented the history of one
mouse.
Experimental design.-The experiment was
designed to measure the effect of added
glycerol on the carcinogenicity of tobacco
condensate. The doses of condensate used
were 189 and 94-5 mg/mouse/week, each
alone or with 17.5% or 35% glycerol, the
balance being made up from solvent (Table I).
These doses were chosen to avoid high-dose
suppression and thus to give optimum tumour
response (Davies et al., 1974), and to be com-
parable with glycerol proportions in NSM
smoke condensate. Control groups received
acetone/glycerol mixtures, or were handled
and not otherwise treated (Table I).
All animals were checked daily and any
abnormality in behaviour or physical con-
dition recorded. Once a week, special atten-
tion was given to the skin, and a count and
initial clinical classification of any tumours
present was made; the exact position and date
of appearance were noted on the mouse's
record card.
Papillomas and suspected sebaceous adeno-
mas were recorded when they appeared to be
greater than 1 mm3 and had been present on
2 consecutive weekly inspections. Papillomas
were recorded as suspected carcinomas when
there was swelling of the tissues beneath the
papilloma, or when it became "fixed" to
underlying tissues and a connection was
suspected; or when sloughing, ulceration or
"rolled edges" were seen. Regression was
recorded when a papilloma completely dis-
appeared. These observations weremadeonall
animals. During the experiment, operator bias
was minimized by ensuring that the same
operator made decisions across all groups.
A full postmortem examination was made
on all animals. Any animal which became
distressed or moribund was killed and
examined. Mice which died were examined
within 24 h of death. Where autolysis was
severe, skin alone was fixed for histological
examination. In 2.5% of control animals
(Groups 1-4) and0.5% oftestanimals (Groups
5-10) all tissues were lost because of autolysis
or cannibalism.
The following tissues were preserved in
formol-corrosive for subsequent histopatho-
logical examination: adrenal, bladder, heart,
stomach, duodenum, jejunum, ileum, caecum,
colon, lungs (after inflation with formol
saline), kidney, liver, mammary tissue, ovary,
pancreas, pituitary, salivary glands, spleen,
thymus (where identifiable), thyroid, uterus
and voluntary muscle. Lymph nodes were
taken where abnormal, or if they were drain-
ing an area with tumour. Grossly abnormal
tissues extra tothosespecified were alsotaken.
The painted area of the skin, and all skin
tumours inside and outside this area, were
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TABLE I.-Experimental design (All groups of 60 mice)
Group
1
2
3
4
5
6
7
8
9
10
Treatment
Undosed control
Solvent control
Low glycerol in solvent
High glycerol in solvent
Low tobacco tar
Low tobacco tar with low glycerol
Low tobacco tar with high glycerol
High tobacco tar
High tobacco tar with low glycerol
High tobacco tar with high glycerol
preserved in Bouin's fixative. Each sample
included some normal skin.
Tissues were examined microscopically for
the presence of tumours. Hyperplasia was
assessed in skin samples where tumours were
not seen. Three pathologists examined the
slides, which were distributed so that each
received material from mice in all experi-
mental groups. Diagnoses were coded for
computer storage.
Analysis of hyperplasia and tumour diag-
nosis was based on criteria previouslyreported
(Clapp et al., 1977).
Statistical methods.-Differences in mor-
tality between groups were compared by the
Logrank test (Peto and Pike, 1973). This
method was also used for the analysis ofskin-
tumour incidence and of the incidence of
hyperplasia. For skin tumours the method
used the time of first appearance of the
tumour. Hyperplasia was treated as if it were
an incidental finding (Peto, 1974) and animals
with skin tumours were omitted. Both
analyses allow for differing mortality rates.
The skin-tumour analysis was done for
Tobacco tar Glycerol
mg/week mg/week
o 0
o 0
0 1575-
0 315
94.5 0
94.5 157-5
94-5 315
189 0
189 157-5
189 315
tumour-bearing animals and for malignant-
tumour-bearing animals.
RESULTS
The general condition of the mice re-
mained good throughout the study, with
no evidence of intercurrent infection.
Animals given the high doses of tobacco
condensate showedsignsofnicotinepoison-
ing during the first few weeks, but there-
after tolerated the dose.
There was some evidence of differences
in mortality between groups (Table II).
This was largely due to a higher mortality
in animals dosed with the high level of
tobacco condensate alone.
Skin tumours
The total number of tumours in the
painted area (Table III) includes con-
nective-tissue tumoursbeneaththepainted
area. All tumours were confirmed histo-
TABLE II.-Cumulative mortality data
Treatment Un-
(Group) treated
control
Weeks
on test
12
24
36
48
60
72
84
96
108
(1)
1
4
5
10
18
21
27
36
47
Solvent Low
control glycerol
and
solvent
(2)
0
1
3
5
9
11
21
33
45
(3)
0
1
1
3
9
13
29
38
47
High
glycerol
and
solvent
(4)
0
0
2
5
9
15
27
40
49
Low Low
tobacco tobacco
and
low
glycerol
(5) (6)
0 0
1 0
1 2
2 5
6 13
14 20
20 30
36 41
50 50
Low
tobacco
and
high
glycerol
(7)
1
2
2
5
8
13
24
28
49
High High
tobacco tobacco
and
low
glycerol
(8) (9)
0 0
1 1
3 1
6 3
9 4
17 16
30 31
45 41
60 51
Some variation between groups. No relationship overall with tobacco or glycerol. The highest mortality
was in Group 8 but this was not evident until Week 96.
High
tobacco
and
high
glycerol
(10)
0
0
1
5
9
14
23
42
53
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TABLE III.-Incidence of skin lesions
Treatment Lc
(Group)
Group size
Animals with normal skins
Animals with hyperplastic skins alone
Animals with benign skins tumours alone
Animals with malignant skin tumours alone
Total animals with skin tumours
Animals with a single skin tumour
Animals with > 1 skin tumour
Low tar
and
low
)w tar glycerol
(5) (6)
60 60
26 26
22 20
8 10
4 4
12 14
7 8
5 6+
+ one animal with fibrosarcoma
++ two animals with fibrosarcoma
TABLE IV.-Comparison within groups without glycerol treatment; Results of Logrank
test
Tumour-bearing animals
Observed no.
Expected no.
O/E
Malignant-tumour-bearing animals
Observed no.
Expected no.
O/E
Low tar
(5)
12
29 - 83
0 40
4
20-02
0-20
High tar
(8)
35
17-17
2 04
29
12 -98
2-23
Significance
X2=29-1
P<0.001
x2=31 *5
P<00001
logically. Only one tumour was seen in a
control animal (Groups 1-4). It occurred
in an undosed animal and proved to be a
sebaceous adenoma. It was first noted at
Week 80.
There was a significant dose-related
tumour responseinanimalstreatedwithto-
bacco condensate alone; the incidence was
20%(12/60)atthelowdose and59% (35/59)
at the high dose. In these tumour-bearing
animals there was an approximately equal
incidence of single and multiple tumours.
Treatment with glycerol affected the
tumour incidence (Tables III, V, VI). At
the low dose of condensate, the high con-
centration of glycerol reduced tumour
incidence by an effect on the number of
animals with multiple tumours. The
incidence ofsingle-tumour-bearers was not
changed. Among animals treated with a
high dose of condensate, both concentra-
tions of glycerol reduced the tumour
incidence, the effect at low concentration
being on the number of animals with
TABLE V.-Comparison within low-tar groups; Results of Logrank test
Tumour-bearing animals
Obs.
Exp.
O/E
Malignant tumour-bearing animals
Obs.
Exp.
O/E
Low Low tar
tar and low
alone glycerol
(5) (6)
12
11-7
1 03
4
4-2
0-96
14
10-2
1-37
4
3 -8
1 -07
Low tar
and high
glycerol
(7)
9
13-1
0-69
5
5-1
0-98
Significance
x2=2-8
(not significant)
x2= =-03
(not significant)
Low tar
and
high
glycerol
(7)
60
33
18
4
5
9
8
1
High tar
and
low
glycerol
(9)
60
8
21
13
18
31
21+
10++
High tar
(8)
59
13
11
6
29
35
18+
17
High tar
and
high
glycerol
(10)
59
25
14
10
10
20
12+
8
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TABLE VI.-Comparison within high tar groups Results ofLogrank test
Tumour-bearing animals
Obs.
Exp.
O/E
Malignant-tumour-bearing animals
Obs.
Exp.
O/E
High
tar
alone
(8)
35
22-7
1-54
29
14- 71
1 -97
multiple tumours, whereas at the high
concentration the effect was a reduction of
both single and multiple tumour-bearing
animals.
The incidence of malignant tumours
(Table III) was also related to dosage of
tobacco condensate, increasing from 7%
(4/60) at the low dose to 49% (29/59) atthe
high dose. Addition of glycerol to the con-
densate reduced this trend where the high
doseofcondensate was used. The effect was
significantandrelated to the concentration
ofglycerol (Tables V and VI). At low doses
of condensate, where there were few
malignant tumours, this effect was not
seen.
Animals with hyperplasia
Since there was a proportion of animals
in all groups in which no skin tumours
developed, an assessment ofhyperplasia of
the epidermis was made in these animals.
Because of the small numbers involved,
results are expressed as "animals with
hyperplasia" in Tables III and VII; the
classification previously described has not
been used.
High tar
and low
glycerol
(9)
High tar
and high
glycerol
(10)
31 20
29-8 33-5
1-04 0-60
18 10
20 -08 22 -2
0 90 0 45
Significance
x2=12-6
P<O-Ol
x2=21-6
P< 0001
The incidence of hyperplasia in control
groups (Table VII) ranged from 2 to 9%,
the group most affected being that which
was clipped and not painted, whereas in
the groups treated with condensate, the
incidence ranged from 35 to 72% (ex-
pressed as a percentage of tumourless
animals). The high concentration of gly-
cerol reduced the incidences ofhyperplasia
in both the low- and high-dose condensate
groups, but low concentrations either
effected no change or actually increased
the incidence.
Tumours other than skin tumours
In assembling the data on general
tumour occurrence, the location ofall sub-
cutaneous tumours was established, and in
only one case was there any doubt whether
the tumour was inside or outside the
painted area. It has been excluded from
consideration as a skin tumour.
The usual variety of tumours which
occur in this strain of mouse was seen. Up
to 29% of animals in a group developed
lymphosarcoma, and the incidences of
pituitary adenoma and tumours of the
TABLE VII.-Incidence of hyperplasia
Treatment Undosed
(Group) control
(1)
Solvent
only
(2)
Low
glycerol
(3)
High Low
glycerol tar
(4) (5)
Low tar
with low
glycerol
(6)
Group size 57 59 58 60 60 60
No. without
tumours 56 59 58 60 48 46
No. with
hyperplasia 5(9) 3(5) 1(2) 1(2) 22(46) 21(4
Figures in parentheses give % incidence in tumourless animals
Low tar
with high
glycerol
(7)
60
High tar
High with low
tar glycerol
(8) (9)
59 60
High tar
with high
glycerol
(10)
59
51 24 29 39
L6) 18(35) 12(50) 21(72) 14(36)
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reproductive system were as expected. An
unexpected result was that there was a
significantly increased incidence of pul-
monary adenoma associated with high
dose of glycerol, but it lay within the
observed incidence of this tumour in this
laboratory (5 to 20%). Benign and malig-
nant tumours occurred in lung, liver,
mammary tissue, Harderian gland an un-
painted skin, but the incidences were low
and none was related to treatment.
DISCUSSION
This work was undertaken to determine
whether the large content of glycerol in
NSM condensate was responsible for the
reduced topical carcinogenicity previously
reported (Clapp et al., 1977). Clycerol,
used as a humectant, constitutes between
40 and 50%0 ofNSM condensate, and there
was a possibility of an effect, other than
dilution, on tumorigenicity. There is no
evidence that the addition of glycerol to
low doses of tobacco-condensate solution
before application to mouse skin affects
the resultant incidence of skin tumours,
but at high doses of condensate the inci-
dence of tumours is very significantly
reduced, and there is also a reduction in the
proportion of malignant tumours. In
addition, the presence of glycerol reduces
the incidence of multiple tumours, a find-
ing hitherto associated with variations in
dose of condensate (Wynder and Hoffman,
1967).
The effects are also dependent on the
amount of glycerol present. The low dose
of glycerol affects only the incidence of
multiple tumours produced by the high
dose of condensate. The high dose of
glycerol has little effect in animals treated
with the low dose of condensate, but again
the incidence of multiple tumours is
significantly reduced. The high dose of
glycerol causes a reduction in the num-
bers of animals affected by the high dose
of condensate, both single tumours
and multiple tumours being significantly
reduced.
The incidence of benign or malignant
tumours (Table III) is dependent on dose
of condensate. Of the animals treated with
the low dose of condensate alone, 700
developed malignant tumours, but at the
high dose, 490o of animals had tumours of
this type. Glycerol treatment had little
effect on the former but the animals re-
ceiving the high dose of condensate
showed a markedly reduced incidence of
malignant tumours with each glycerol
treatment (to 25% and 15% respectively).
Previous studies with tobacco conden-
sate in this laboratory (Clapp et al., 1977)
showed an observed incidence of 4400
tumour-bearing animals at a dose of
210 mg. The incidence in this study is
greater (59%) at a dose of 189 mg. This
increase is possibly related to the different
strain of mouse (Alderley Park instead of
Carworth) or to the different solvent
formulation. These variations do not
affect the significance of the findings of
the present study. The study shows the
increased incidence of malignant and
multiple tumours commonly seen as the
dose of condensate is increased.
In the earlier experiment, the com-
parable incidence of tumours obtained
with NSM condensate at a dose of
210 mg was 4.5%, whereas in the present
experiment, when tobacco condensate at
189 mg was diluted with 62.5% (w/w)
glycerol, the incidence was 320o. These
results suggest that dilution of condensate
with glycerol cannot entirely account for
the greatly reduced carcinogenicity of
NSM condensate. Even though the tumour
response is not directly proportional to the
dose (Conning, 1975) the very small
incidence of tumours after NSM treatment
must result from reduced activity of
particulate-phase material, or some effect
of glycerol other than dilution.
In addition to the influence on tumour
incidence, the presence of glycerol has an
effect on animals not developing skin
tumours. The combination of a high
glycerol level with both levels of conden-
sate produces an increase in the number of
tumourless animals. Of these animals, the
proportion unaffected increases with the
255SJ. WILSON, M. J. L. CLAPP AND D. M. CONNING
Low tar Low tar
Low tar with low with high
glycerol glycerol
(r,) (r;) (7)
100
90
80
C 70
C' 60
a)
0
c
(D 50
*0
a)
C) 40
c
8 30
20
10
n
v o) kJ \
High tar High tar
High tar with low with high
olvsr,ml alvcerol
malignant neoplasia hyperplasia
benign neoplasia normal skin
FIG. Variation in skin lesions with glycerol
treatment.
glycerol concentration, thus reducing the
proportion with hyperplasia (Table VII).
The significantly increased incidence of
hyperplasia in Group 9 (high-dose con-
densate/low glycerol) is probably related
to the reduction intumour-bearinganimals
in that group. In effect, glycerol appears to
modify the incidence of malignant
tumours, benign tumours, hyperplastic
changes and unaffected skin (Table III
and Fig.). This suggests a sequential
relationship between epithelial hyper-
plasia, benign tumours and malignant
tumours of skin in response to topical
carcinogens, with glycerol impeding the
conversion ofhyperplasia to neoplasia and
the transition of benign to malignant
tumours and, at high dose, inhibiting skin
hyperplasia.
How this sequence is modified by
glycerol could be of some importance and
there are a number of mechanisms which
might operate.
First, it is possiblethatglycerolproduces
a phase separation of condensate, with the
carcinogenic residues located in one phase
(Chortyk and Bock, 1976). Failure to tap
this phase during application to skin
would reduce the incidence of tumours.
The precaution of shaking the solution
before application would avoid such an
effect.
A second possible mechanism could
depend upon the relative solubility of the
carcinogens. Lee et al. (1977) have shown
that virtually all the carcinogenic com-
ponents of whole-smoke condensate are
insoluble in water. Davies et al. (1974)
demonstrated that the use of a hydro-
phobic alcohol (isopropyl alcohol) as a
solvent for condensate increased the
incidence of tumours over that achieved
with the usual solvents. The present study,
using a hydrophilic alcohol, has reduced
the incidence. This effect could thus be
related to the relative insolubility of the
carcinogen in fatty materials such as
sebum and to its consequently reduced
absorption; or to a reduced rate of cell
penetration.
A third possible mechanism might be
that glycerol, being less volatile than
acetone, merely holds the relevant car-
cinogens on the surface of the skin for a
longer period of time, thus reducing the
rate ofabsorption. Such an effect might be
compounded by the removal ofthe applied
material by natural grooming. Ifthe latter
occurred to any extent, a tumourous effect
in the stomach might have been expected,
due to the ingested benzpyrene (Neal and
Rigdon, 1967).
Finally it is conceivable that the inhibi-
tory effect is exerted at a cellular level, by
impeding either cell absorption or intra-
cellular transport in some way.
Whatever the mechanism, the presence
ofglycerol appears to exert an effect which
would be beneficial to smokers if these
findings were applicable in the human
situation. The findings, however, could not
account for all of the advantages demon-
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strable for NSM, and it is probable that
NSM condensate is basically much less
active than tobacco condensate, even in
the absence of glycerol.
The authors thank T. Weight for statistical
analyses and Sheila Scarrott and Lynette Bentley for
secretarial assistance.
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